Cargando…

Prevalence of Drug–Drug Interactions with Hormonal Contraceptives and Antiretrovirals in Women Living with HIV

BACKGROUND: The use of contraception for family planning is critically important for women living with HIV (WLH), but barriers to co-use of hormonal contraceptives (HC) and antiretroviral therapy (ART) exist due to drug-drug interaction (DDI) potential. The objective of this study was to describe th...

Descripción completa

Detalles Bibliográficos
Autores principales:	McLaughlin, Milena M, Jensen, Ashley, Cohn, Susan, Darin, Kristin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630935/ http://dx.doi.org/10.1093/ofid/ofx163.1765

Ejemplares similares

Potential risk of drug–drug interactions with hormonal contraceptives and antiretrovirals: prevalence in women living with HIV
por: Murray, Milena M, et al.
Publicado: (2020)

Drug interactions between hormonal contraceptives and antiretrovirals
por: Nanda, Kavita, et al.
Publicado: (2017)

Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV
por: McLaughlin, Milena M, et al.
Publicado: (2018)

Hormonal contraceptive use in HIV-infected women using antiretroviral therapy: a systematic review
por: Womack, Julie A, et al.
Publicado: (2015)

Contraception for the HIV-Positive Woman: A Review of Interactions between Hormonal Contraception and Antiretroviral Therapy
por: Robinson, Jennifer A., et al.
Publicado: (2012)

Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?
por: Bukkems, Vera E., et al.
Publicado: (2020)

Hormonal contraception, sexual behaviour and HIV prevalence among women in Cameroon
por: Kongnyuy, Eugene J, et al.
Publicado: (2008)

Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain
por: Castro-Granell, Vanessa, et al.
Publicado: (2021)

Longitudinal patterns of unmet need for contraception among women living with HIV on antiretroviral therapy in South Africa
por: Rucinski, Katherine B., et al.
Publicado: (2018)

Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women
por: Wall, Kristin M., et al.
Publicado: (2016)

Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
por: Scarsi, Kimberly, et al.
Publicado: (2014)

Preconception and Contraceptive Care for Women Living with HIV
por: Hoyt, Mary Jo, et al.
Publicado: (2012)

Prescribing issues in older adults living with HIV: thinking beyond drug–drug interactions with antiretroviral drugs
por: Livio, Françoise, et al.
Publicado: (2019)

Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception
por: Kancheva Landolt, Nadia, et al.
Publicado: (2017)

Pregnancies among women living with HIV using contraceptives and antiretroviral therapy in western Kenya: a retrospective, cohort study
por: Patel, Rena C., et al.
Publicado: (2021)

Prevalence and management of drug–drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study
por: Schlaeppi, C, et al.
Publicado: (2019)

Use of High-Dose Oral Valacyclovir During an Intravenous Acyclovir Shortage: A Retrospective Analysis of Tolerability and Drug Shortage Management
por: McLaughlin, Milena M., et al.
Publicado: (2017)

Hormonal Contraceptive Use Among HIV-Positive Women and HIV Transmission Risk to Male Partners, Zambia, 1994–2012
por: Wall, Kristin M., et al.
Publicado: (2016)

The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV
por: Rojo, Pablo, et al.
Publicado: (2020)

Bacterial vaginosis modifies the association between hormonal contraception and HIV acquisition
por: Haddad, Lisa B., et al.
Publicado: (2018)

Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia
por: Miti, Sam, et al.
Publicado: (2020)

Hormonal contraception and HIV acquisition among women: an updated systematic review
por: Curtis, Kathryn M, et al.
Publicado: (2020)

Contraceptive Characteristics of Women Living with HIV in the Kumasi Metropolis, Ghana
por: Gyimah, Akosua A., et al.
Publicado: (2013)

Reproductive Plans And Utilization of Contraceptives Among Women Living With HIV
por: Adeleye, Khadija Kofoworola, et al.
Publicado: (2019)

Contraception, punishment and women who use drugs
por: Olsen, Anna, et al.
Publicado: (2014)

Prevalence of and Barriers to Dual-Contraceptive Methods Use among Married Men and Women Living with HIV in India
por: Chakrapani, Venkatesan, et al.
Publicado: (2011)

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
por: Charpentier, Charlotte, et al.
Publicado: (2023)

Benefits and risks of hormonal contraception for women
por: Gorenoi, Vitali, et al.
Publicado: (2007)

Establishing a Multidisciplinary Framework to Study Drug‐Drug Interactions of Hormonal Contraceptives: An Invitation to Collaborate
por: Lesko, Lawrence J., et al.
Publicado: (2018)

Treatment outcome of different antiretroviral drug regimens in HIV-positive pregnant women
por: Chauhan, Nidhi, et al.
Publicado: (2021)

Drug-Eluting Fibers for HIV-1 Inhibition and Contraception
por: Ball, Cameron, et al.
Publicado: (2012)

Follicle‐stimulating hormone in postmenopausal women living with HIV: a prevalence study
por: Tariq, Shema, et al.
Publicado: (2021)

Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks
por: Scarsi, Kimberly K., et al.
Publicado: (2016)

The injection or the injection? Restricted contraceptive choices among women living with HIV
por: Towriss, Catriona A., et al.
Publicado: (2019)

Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
por: Castro, Hannah, et al.
Publicado: (2012)

Trends in Antiretroviral Therapy and Prevalence of HIV Drug Resistance Mutations in Sweden 1997–2011
por: Bontell, Irene, et al.
Publicado: (2013)

Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
por: Gaytán-Martínez, JE, et al.
Publicado: (2010)

A Pharmacoepidemiologic Approach to Evaluate Real-world Effectiveness of Hormonal Contraceptives in the Presence of Drug–drug Interactions
por: Sarayani, Amir, et al.
Publicado: (2020)

Antiretroviral drug use by individuals living with HIV/AIDS and compliance with the Clinical Protocol and Therapy Guidelines
por: Brojan, Lucas Eduardo Fedaracz, et al.
Publicado: (2020)

Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries
por: Crowell, Trevor A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7lknjk592i9g6p27u48rgnrunj